Compound Detail
CHEMBL4100350
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4100350 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SEOODRZFNALTHG-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
408.4
MW (Da)
3.39
ALogP
6
HBA
1
HBD
73.5
PSA (Ų)
0.71
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.39
IC50 1 meas. best 5.77
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 5.39 | 5.39 | 4100.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 1700.0 | nM | 5.77 | Inhibition of RNase H activity of full length HIV reverse transcriptase using RN... | 28182989 |
| Human immunodeficiency virus 1 | EC50 | = | 4100.0 | nM | 5.39 | Antiviral activity against HIV1 infected in human P4R5 cells assessed as reducti... | 28182989 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28182989 | 10.1016/j.ejmech.2017.01.041 | Unchecked | 4 |
| 28182989 | 10.1016/j.ejmech.2017.01.041 | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine